RecruitingNCT06021340
What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?
Sponsor
Chinese University of Hong Kong
Enrollment
50 participants
Start Date
Jul 4, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Various to-be-discard material from IVF treatment cycle will be collect and examined, aiming to identify potential reasons of successful outcome or cycle failure.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patients attending the Assisted Reproductive Technology (ART) Unit of the Chinese University of Hong Kong for ART treatment.
- Participant able to give voluntary, written, informed consent to participate in the study.
Exclusion Criteria2
- Patient using donor gamete in IVF treatment
- Patient refuses to join and failed to giving consent for any reasons
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06021340
Related Trials
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
NCT054406171 location
Inherited Reproductive Disorders
NCT015004472 locations
The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study
NCT072263101 location
Aromatherapy for Mental Health Promotion in IVF Patients
NCT074806681 location
AI-TOP Study Artificial Intelligence for Trigger Optimization.
NCT075151185 locations